Journal of Clinical Virology
Volume 44, Issue 4 , Pages 314-317 , April 2009

High level of HPV 16 and 18 DNA load in anal swabs from male and female HIV-1 infected patients

  • Isabelle Poizot-Martin

      Affiliations

    • Departement de Recherche Clinique CHU Sainte-Marguerite, Marseille, France
    • ,
  • Mireille Henry

      Affiliations

    • Fédération de Microbiologie Hospitalière, URMITE CNRS-IRD UMR 6236, CHU la Timone, France
    • ,
  • Serge Benhaim

      Affiliations

    • Departement de Recherche Clinique CHU Sainte-Marguerite, Marseille, France
    • ,
  • Véronique Obry-Roguet

      Affiliations

    • Departement de Recherche Clinique CHU Sainte-Marguerite, Marseille, France
    • ,
  • Dominique Figarella

      Affiliations

    • Laboratoire d’Anatomie-Pathologique, CHU la Timone, APHM, Marseille, France
    • ,
  • Catherine Tamalet

      Affiliations

    • Fédération de Microbiologie Hospitalière, URMITE CNRS-IRD UMR 6236, CHU la Timone, France
    • Corresponding Author InformationCorresponding author at: Laboratoire de Virologie Hôpital de la Timone, 264 Rue St Pierre, 13385 Marseille Cedex 05, France. Tel.: +33 4 91 38 55 22; fax: +33 4 91 38 55 18.

Received 10 September 2008 ,Revised 27 January 2009 ,Accepted 4 February 2009.

References 

  1. Palefsky JM, Holly EA, Hogeboom JC, Relston ML, Da Costa MM, Botts R, et al. Virologic, immunologic and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:314–319
  2. Bower M, Powles T, Newsom-Davis T, Thirlwell C, Stebbing J, Mandalia S, et al. HIV-associated anal cancer. Has highly active antiretroviral therapy reduced the incidence or improved the outcome?. J Acquir Immune Defic Syndr. 2004;37:1563–1565
  3. Piketty C, Darragh TM, Heard I, Da Costa M, Bruneval P, Kazatchkine M, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis. 2004;31:96–99
  4. Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS. 2008;22:1203–1211
  5. Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull. 2002;49:194–209
  6. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis. 2001;183:383–391
  7. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357:1579–1588
  8. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007;357:1589–1597
  9. Bulmans NWJ, Berkhof J, Rozendaal L, Boeke AJP, Bulk S, Voorhost FJ, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007;370:1764–1772
  10. Moberg M, Gustavsson L, Gyllenstein U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol. 2003;41:3221–3228
  11. Low KW, Yeung SW, Cheung TH, Siu NS, Kahn T, Wong YF. Quantitative analysis of human papillomavirus type 16 on cervical neoplasm: a study in Chinese population. J Clin Virol. 2005;34:76–80
  12. Carcopino X, Henry M, Benmoura D, Fallabregues AS, Richet H, Boubli L, et al. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy. J Med Virol. 2006;78:1131–1140
  13. Weissenborn SJ, Funke AM, Hellmich M, Mallmann P, Fuchs PG, Pfister HJ, et al. J Clin Microbiol. 2003;41:2763–2767
  14. Lefevre J, Hankins C, Pourreau K, Coutlée F the Canadian Women's HIV study Group. Human papillomavirus type 16 viral load is increased in HIV-seropositive women with high-grade squamous intraepithelial lesions compared to those with normal cytology smears. J Clin Microbiol. 2004;42:2212–2215
  15. Yeni P. Management of patients infected by the human immunodeficiency virus. Report of an expert group: Flammarion Medicine-Sciences; 2006, p. 266–7.
  16. Nicollas R, Henry M, Triglia JM, Tamalet C. HPV type 6 and 16 co-infection in a 11-year old girl presenting laryngeal papillomatosis. J Clin Virol. 2007;40:252–254
  17. Palefsky JM, Holly EA, Ralston EA, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV) positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361–367
  18. Palefsky JM, Holly EA, Efirdc JT, Da Costa M, Jay N, Berry JM, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS. 2005;19:1407–1414
  19. Sirera G, Videla S, Pinol M, Canada MP, Llatjos M, Ballesteros AL, et al. High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS. 2006;20:1201–1204
  20. Orlando G, Tanzi E, Beretta R, Amendola A, Fasolo MM, Bianchi S, et al. Human Papillomavirus genotypes and anal-related lesions among HIV-1 infected men in Milan, Italy. J Acquir Immune Defic Syndr. 2007;47:129–131
  21. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001;357:1831–1836
  22. Liaw KL, Glass AG, Manos MM, Greer CE, Scott DR, Sherman M, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst. 1999;91:954–960
  23. Bachtiary B, Obermair G, Dreier B, Bimer P, Breitenecker G, Knocke TH, et al. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer. 2002;102:237–243
  24. Van der Graaf Y, Molijn A, Doornewaard H, Quint W, Van Doorn LJ, Van den Tweel J. Human Papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol. 2002;156:158–164
  25. Dalstein V, Riethmuller D, Pretet JL, Le Bail Carval KL, Sautière JL, Carbillet JP, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer. 2003;106:396–403
  26. Van Duin M, Snijders PJ, Schrijnrmaakers HF, Voohorst FJ, Rozendaal L, Nobbenhuis MA, et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CINII/III and viral clearance. Int J Cancer. 2002;98:590–595
  27. Drobacheff C, Dupont P, Mougin C, Bourezane Y, Challier B, Fantoli M, et al. Anal human papillomavirus DNA screening by Hybrid Capture IITM in human immunodeficiency virus-positive patients with or without anal intercourse. Eur J Dermatol. 2003;13:367–371
  28. Pierangeli A, Scagnolari C, Degener AM, Bucci M, Ciardi A, Riva E, et al. Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men. AIDS. 2008;22:1929–1935
  29. Kreuter A, Wieland U, Gambichler T, Altmeyer P, Pfister H, Tenner-Racz , et al. p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immuno-deficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load. Br J Dermatol. 2007;157:523–530

PII: S1386-6532(09)00076-6

doi: 10.1016/j.jcv.2009.02.003

Journal of Clinical Virology
Volume 44, Issue 4 , Pages 314-317 , April 2009

Article Tools

* Image Usage & Resolution